Fore Biotherapeutics

Philadelphia, PA

Fore Biotherapeutics is a precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics.

Claim this profile

Employbl Premium

Get the inside track on Fore Biotherapeutics

Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.

AI chat about Fore Biotherapeutics's culture, stack, and interview process
Save jobs and get alerts on new openings
Full premium profiles across our company index
7-day free trial, then $25/mo. Cancel anytime.

Start free trial →Already have an account? Sign in

Company Details

Founded: 2011
Employees: Between 20 - 100 employees
Raised: $206,700,000
Headquarters Location: Philadelphia, PA
Public: No
Acquired: No
CEO: William R Hinshaw
Founders: Matthew Ros

Company Collections

These are collections Fore Biotherapeutics is a part of. Click on the collection name to view similar companies.

Fore Biotherapeutics' Industries

Software Companies

Medical Organizations

Health Care Companies

Biotechnology Companies

Fore Biotherapeutics' Tech Stack

Fore Biotherapeutics Headquarters Location

Philadelphia, PA 19132

Total Amount Raised: $206,700,000

Fore Biotherapeutics Funding Rounds

Series D
$40,200,000
May 6, 2025
Series D
$40,200,000
May 5, 2025
Series D Investors
SR One
Cormorant Asset Management
HBM Healthcare Investments
Wellington Management
Novartis Venture Fund
OrbiMed Advisors
Medicxi
3B Future Health Fund
Series D
$75,000,000
Aug 23, 2023
Series D
$75,000,000
Aug 22, 2023
Series D Investors
Medicxi
SR One
Cormorant Asset Management
Samsung Securities
3B Future Health Fund
OrbiMed Advisors
Wellington Management
Novartis Venture Fund
HBM Partners
Series C
$57,000,000
Sep 21, 2020
Series C
$57,000,000
Sep 20, 2020
Series C Investors
Pontifax
Cormorant Asset Management
HBM Healthcare Investments
SR One
Wellington Management
OrbiMed Advisors
Novartis Venture Fund
Series Unknown
$6,000,000
Apr 30, 2018
Series Unknown
$6,000,000
Apr 29, 2018
Series Unknown Investors
SICAR
Bio Capital Impact Fund
Windham Venture Partners
3B Future Health Fund
Series Unknown
$2,500,000
Jun 22, 2016
Series Unknown
$2,500,000
Jun 21, 2016
Series Unknown Investors
OrbiMed Advisors
Series Unknown
$10,000,000
Dec 23, 2015
Series Unknown
$10,000,000
Dec 22, 2015
Series Unknown Investors
Intercure
Seed
$8,000,000
Jul 1, 2014
Seed
$8,000,000
Jun 30, 2014
Seed
$8,000,000
Jul 1, 2013
Seed
$8,000,000
Jun 30, 2013

Funding info provided by Diffbot.

Fore Biotherapeutics Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Fore Biotherapeutics.